SK BIOPHARMACEUTICALS financial statements, including revenue, expenses, profit, and loss

The total revenue of 326030 for the last quarter is 136.60 B KRW, and it's 1.95% higher compared to the previous quarter. The net income of Q3 24 is 6.31 B KRW.